Ha Tay Pharmaceutical JSC (HNX:DHT)

Market Cap	7.16T
Revenue (ttm)	2.08T
Net Income (ttm)	78.43B
Shares Out	82.34M
EPS (ttm)	952.50
PE Ratio	91.34
Forward PE	n/a
Dividend	1,000.00 (1.15%)
Ex-Dividend Date	Oct 30, 2024

Volume	25,635
Average Volume	23,491
Open	84,600
Previous Close	86,000
Day's Range	84,600 - 87,400
52-Week Range	62,200 - 110,900
Beta	0.38
RSI	59.18
Earnings Date	Aug 7, 2025

About Checkpoint Therapeutics

Ha Tay Pharmaceutical JSC manufactures, trades in, imports, and exports medicines, chemical raw materials for medicine, medicinal materials, and medical equipment. In addition, the company provides medicinal products manufacturing services; and import-export authorization services, as well as supplies pharmaceutical ingredients for enterprises. The company was founded in 1965 and is based in Hanoi, Vietnam.

• Industry: Pharmaceutical Preparations
• Founded: 1965
• Country: Vietnam
• Stock Exchange: Hanoi Stock Exchange
• Ticker Symbol: DHT

Financial Performance

In 2024, Ha Tay Pharmaceutical JSC's revenue was 2.09 trillion, an increase of 4.35% compared to the previous year's 2.00 trillion. Earnings were 71.77 billion, a decrease of -15.62%.